This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,390.87, is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in units of 30. It is a firm fixed-price delivery order contract with a completion date of February 27, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,117.33 and is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets. The contract has an ultimate completion date of October 23, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,507.44, is for the delivery of 4560843381 - Telmisartan-HCTZ 80-12.5 mg tablets in units of 30s. The contract has a firm fixed price and has a completion date of May 8, 2023. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,815.04, is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The contract has a period of performance through December 6, 2024 and is a firm fixed-price delivery order contract. No set-aside designation is noted. AmerisourceBergen is the prime contractor...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets. The $2,643.33 firm fixed price contract has a completion date of February 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $16,414.09 firm-fixed-price contract is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in units of 30. The contract has an ultimate completion date of August 2, 2024. Amerisourcebergen, as a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,431.30, is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets. It is a firm fixed-price contract with a completion date of February 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets, a cardiovascular medication, with a ceiling value of $88,286.42 and a completion date of January 27, 2025. The contract is a firm-fixed price, delivery order type with no set-aside designation, indicating open competition. AmerisourceBergen is a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The contract is a firm fixed-price delivery order with a ceiling value of $5,608.56 and a period of performance through January 27, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $10,929.26, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets. The contract has a firm fixed-price pricing type and an ultimate completion date of January 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...